BSESandu Pharmaceuticals LtdMinimalNeutral
Announced Tue, 30 Sept · 15:20 IST

intimation to the holders of physical securities to furnish PAN and KYC details as per SEBI master circular dated June 23,2025

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sandu Pharmaceuticals has sent a reminder to shareholders who still hold shares in physical (paper) form, asking them to update their PAN, address, mobile number, bank account details, specimen signature, and nomination details with the company's Registrar and Transfer Agent, MUFG Intime India Private Limited. As per SEBI's master circular, shareholders who do not complete these KYC updates will only receive dividend payments electronically once the details are furnished. The company has also urged physical shareholders to convert their holdings into dematerialised (demat) form, since transfer of physical shares has not been permitted since April 1, 2019, and demat holdings offer better liquidity.

Likely market impact

This is a routine regulatory compliance communication and does not impact the company's financials or operations. Shareholders holding Sandu Pharmaceuticals shares in physical form should update their KYC details and consider dematerialising their shares to avoid delays in receiving dividends and to maintain liquidity.